100 related articles for article (PubMed ID: 11797507)
1. Joint accumulations of FDG in whole body PET scans.
von Schulthess GK; Meier N; Stumpe KD
Nuklearmedizin; 2001 Dec; 40(6):193-7. PubMed ID: 11797507
[TBL] [Abstract][Full Text] [Related]
2. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints.
Kubota K; Ito K; Morooka M; Mitsumoto T; Kurihara K; Yamashita H; Takahashi Y; Mimori A
Ann Nucl Med; 2009 Nov; 23(9):783-91. PubMed ID: 19834653
[TBL] [Abstract][Full Text] [Related]
3. F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis.
Goerres GW; Forster A; Uebelhart D; Seifert B; Treyer V; Michel B; von Schulthess GK; Kaim AH
Clin Nucl Med; 2006 Jul; 31(7):386-90. PubMed ID: 16785804
[TBL] [Abstract][Full Text] [Related]
4. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations.
Engel H; Steinert H; Buck A; Berthold T; Huch Böni RA; von Schulthess GK
J Nucl Med; 1996 Mar; 37(3):441-6. PubMed ID: 8772641
[TBL] [Abstract][Full Text] [Related]
5. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
[TBL] [Abstract][Full Text] [Related]
6. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management.
Basu S; Houseni M; Alavi A
Nucl Med Commun; 2008 Apr; 29(4):367-73. PubMed ID: 18317302
[TBL] [Abstract][Full Text] [Related]
7. Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT.
Rosen RS; Fayad L; Wahl RL
J Nucl Med; 2006 Aug; 47(8):1274-80. PubMed ID: 16883005
[TBL] [Abstract][Full Text] [Related]
8. The implications of 18F-FDG PET for the diagnosis of endoprosthetic loosening and infection in hip and knee arthroplasty: results from a prospective, blinded study.
Delank KS; Schmidt M; Michael JW; Dietlein M; Schicha H; Eysel P
BMC Musculoskelet Disord; 2006 Mar; 7():20. PubMed ID: 16512924
[TBL] [Abstract][Full Text] [Related]
9. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis.
Tatsumi M; Cohade C; Nakamoto Y; Wahl RL
Radiology; 2003 Dec; 229(3):831-7. PubMed ID: 14593193
[TBL] [Abstract][Full Text] [Related]
10. CT-based tissue segmentation to assess knee joint inflammation and reactive bone formation assessed by
Al-Zaghal A; Yellanki DP; Ayubcha C; Werner TJ; Høilund-Carlsen PF; Alavi A
Hell J Nucl Med; 2018; 21(2):102-107. PubMed ID: 30006643
[TBL] [Abstract][Full Text] [Related]
11. Intra-individual variability of cardiac uptake on serial whole-body 18F-FDG PET.
Khandani AH; Isasi CR; Donald Blaufox M
Nucl Med Commun; 2005 Sep; 26(9):787-91. PubMed ID: 16096582
[TBL] [Abstract][Full Text] [Related]
12. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Cohade C; Osman M; Pannu HK; Wahl RL
J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
[TBL] [Abstract][Full Text] [Related]
13. Persistent non-specific FDG uptake on PET imaging following hip arthroplasty.
Zhuang H; Chacko TK; Hickeson M; Stevenson K; Feng Q; Ponzo F; Garino JP; Alavi A
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1328-33. PubMed ID: 12271415
[TBL] [Abstract][Full Text] [Related]
14. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results.
Kamel EM; Thumshirn M; Truninger K; Schiesser M; Fried M; Padberg B; Schneiter D; Stoeckli SJ; von Schulthess GK; Stumpe KD
J Nucl Med; 2004 Nov; 45(11):1804-10. PubMed ID: 15534047
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET.
Pandit-Taskar N; Schöder H; Gonen M; Larson SM; Yeung HW
AJR Am J Roentgenol; 2004 Oct; 183(4):1143-7. PubMed ID: 15385321
[TBL] [Abstract][Full Text] [Related]
16. [18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation.
Buchmann I; Vogg AT; Glatting G; Schultheiss S; Möller P; Leithäuser F; Schulte M; Gfrörer W; Kotzerke J; Reske SN
Cancer Biother Radiopharm; 2003 Jun; 18(3):327-37. PubMed ID: 12954120
[TBL] [Abstract][Full Text] [Related]
17. Normal FDG distribution patterns in the head and neck: PET/CT evaluation.
Nakamoto Y; Tatsumi M; Hammoud D; Cohade C; Osman MM; Wahl RL
Radiology; 2005 Mar; 234(3):879-85. PubMed ID: 15734938
[TBL] [Abstract][Full Text] [Related]
18. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.
Roivainen A; Parkkola R; Yli-Kerttula T; Lehikoinen P; Viljanen T; Möttönen T; Nuutila P; Minn H
Arthritis Rheum; 2003 Nov; 48(11):3077-84. PubMed ID: 14613269
[TBL] [Abstract][Full Text] [Related]
19. Nodal staging of lymphoma with whole-body PET: comparison of.
Sutinen E; Jyrkkiö S; Varpula M; Lindholm P; Grönroos T; Lehikoinen P; Teräs M; Minn H
J Nucl Med; 2000 Dec; 41(12):1980-8. PubMed ID: 11138682
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma].
Thill R; Neuerburg J; Fabry U; Cremerius U; Wagenknecht G; Hellwig D; Osieka R; Günther R; Büll U
Nuklearmedizin; 1997 Oct; 36(7):234-9. PubMed ID: 9441282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
